Strumento inattivo

Azioni Biondvax Pharmaceuticals Ltd

Azioni

Prezzo di chiusura TEL AVIV STOCK EXCHANGE Altri mercati azionari
- ^ILa	-

Biondvax Pharmaceuticals : Announces Rights Offering Fully Subscribed at US$20 Million	16/07/19
Biondvax Pharmaceuticals : First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial	08/07/19
Biondvax Pharmaceuticals : European Investment Bank VP attends Signature Event at BiondVax Extending Financing Agreement with BiondVax to €24 million	26/06/19
Biondvax Pharmaceuticals : Patent Covering Manufacturing Process of BiondVax’s M-001 Universal Flu Vaccine Allowed in USA and Japan	18/06/19
Biondvax Pharmaceuticals : Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu Vaccine and Scale Up of Manufacturing Process	10/06/19

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+41,79%	54,04 Mrd
IQVIA HOLDINGS INC.	-0,56%	41,92 Mrd
LONZA GROUP AG	+48,83%	41,96 Mrd
CELLTRION, INC.	-7,20%	28,35 Mrd
ICON PUBLIC LIMITED COMPANY	+12,59%	26,35 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-21,51%	19 Mrd
BIO-TECHNE CORPORATION	+6,92%	13 Mrd
UNITED THERAPEUTICS CORPORATION	+24,91%	12,19 Mrd
MEDPACE HOLDINGS, INC.	+29,60%	12,28 Mrd